NIOX Group Plc (NIOX.L)
LSE · GBp · Healthcare · Medical Devices
£69.10 (+3.13%) as of
Key statistics
- Market cap
- 280.01M
- P/E (TTM)
- 34.55
- Forward P/E
- 19.61
- EPS (TTM)
- 0.02
- Dividend yield
- 2.31%
- 52-week range
- 53.84 – 80.00
- Beta
- -0.04
- Revenue (TTM)
- 47.5M
- Profit margin
- 14.74%
- Analyst target
- £82.40
- Volume
- 100.36k
About NIOX Group Plc
NIOX Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis, monitoring, and management of asthma and COPD worldwide. The company offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device, sensors, individual disposable mouthpieces, and breathing handles for the measurement of fractional exhaled nitric oxide (FeNO) level in patients. The company was formerly known as Circassia Group Plc and changed its name to NIOX Group Plc in September 2022. NIOX Group Plc was incorporated in 2006 and is headquartered in Oxford, the United Kingdom.
- Sector
- Healthcare
- Industry
- Medical Devices
- Headquarters
- Oxford, United Kingdom
- Employees
- 97
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.